81 related articles for article (PubMed ID: 10716904)
1. Helper T-cell epitope immunodominance associated with structurally stable segments of hen egg lysozyme and HIV gp120.
Landry SJ
J Theor Biol; 2000 Apr; 203(3):189-201. PubMed ID: 10716904
[TBL] [Abstract][Full Text] [Related]
2. Breaking of B cell tolerance toward a highly conserved self protein.
Dalum I; Jensen MR; Hindersson P; Elsner HI; Mouritsen S
J Immunol; 1996 Dec; 157(11):4796-804. PubMed ID: 8943381
[TBL] [Abstract][Full Text] [Related]
3. Immunodominance is independent of structural constraints: each region within hen eggwhite lysozyme is potentially available upon processing of native antigen.
Moudgil KD; Sekiguchi D; Kim SY; Sercarz EE
J Immunol; 1997 Sep; 159(6):2574-9. PubMed ID: 9300675
[TBL] [Abstract][Full Text] [Related]
4. Allocation of helper T-cell epitope immunodominance according to three-dimensional structure in the human immunodeficiency virus type I envelope glycoprotein gp120.
Dai G; Steede NK; Landry SJ
J Biol Chem; 2001 Nov; 276(45):41913-20. PubMed ID: 11551929
[TBL] [Abstract][Full Text] [Related]
5. Design of immunogens that present the crown of the HIV-1 V3 loop in a conformation competent to generate 447-52D-like antibodies.
Chakraborty K; Durani V; Miranda ER; Citron M; Liang X; Schleif W; Joyce JG; Varadarajan R
Biochem J; 2006 Nov; 399(3):483-91. PubMed ID: 16827663
[TBL] [Abstract][Full Text] [Related]
6. Conformational instability governed by disulfide bonds partitions the dominant from subdominant helper T-cell responses specific for HIV-1 envelope glycoprotein gp120.
Nguyen HN; Steede NK; Robinson JE; Landry SJ
Vaccine; 2015 Jun; 33(25):2887-96. PubMed ID: 25944298
[TBL] [Abstract][Full Text] [Related]
7. Antigen three-dimensional structure guides the processing and presentation of helper T-cell epitopes.
Carmicle S; Steede NK; Landry SJ
Mol Immunol; 2007 Feb; 44(6):1159-68. PubMed ID: 16893568
[TBL] [Abstract][Full Text] [Related]
8. Polyhistidine-tagged hepatitis B core particles as carriers of HIV-1/gp120 epitopes of different HIV-1 subtypes.
Wizemann H; Weiland F; Pfaff E; von Brunn A
Biol Chem; 2000 Mar; 381(3):231-43. PubMed ID: 10782994
[TBL] [Abstract][Full Text] [Related]
9. Human T-helper cell recognition of an immunodominant epitope of HIV-1 gp120 expressed on the surface of Streptococcus gordonii.
Pozzi G; Oggioni MR; Manganelli R; Medaglini D; Fischetti VA; Fenoglio D; Valle MT; Kunkl A; Manca F
Vaccine; 1994 Sep; 12(12):1071-7. PubMed ID: 7998415
[TBL] [Abstract][Full Text] [Related]
10. Antigen structure influences helper T-cell epitope dominance in the human immune response to HIV envelope glycoprotein gp120.
Mirano-Bascos D; Tary-Lehmann M; Landry SJ
Eur J Immunol; 2008 May; 38(5):1231-7. PubMed ID: 18398933
[TBL] [Abstract][Full Text] [Related]
11. Mapping of a protective helper T cell epitope of human influenza A virus hemagglutinin.
Gogolák P; Simon A; Horváth A; Réthi B; Simon I; Berkics K; Rajnavölgyi E; Tóth GK
Biochem Biophys Res Commun; 2000 Apr; 270(1):190-8. PubMed ID: 10733926
[TBL] [Abstract][Full Text] [Related]
12. Increasing the frequency of T-cell precursors specific for a cryptic epitope of hen-egg lysozyme converts it to an immunodominant epitope.
Thatcher TH; O'Brien DP; Altuwaijri S; Barth RK
Immunology; 2000 Feb; 99(2):235-42. PubMed ID: 10692042
[TBL] [Abstract][Full Text] [Related]
13. Efficient CD8+ T cell response to the HIV-env V3 loop epitope from multiple virus isolates by a DNA prime/vaccinia virus boost (rWR and rMVA strains) immunization regime and enhancement by the cytokine IFN-gamma.
Gómez CE; Abaitua F; Rodríguez D; Esteban M
Virus Res; 2004 Sep; 105(1):11-22. PubMed ID: 15325077
[TBL] [Abstract][Full Text] [Related]
14. Hindering auxiliary anchors are potent modulators of peptide binding and selection by I-Ak class II molecules.
Latek RR; Petzold SJ; Unanue ER
Proc Natl Acad Sci U S A; 2000 Oct; 97(21):11460-5. PubMed ID: 11016975
[TBL] [Abstract][Full Text] [Related]
15. Mutation of the invariant chain transmembrane region inhibits II degradation, prolongs association with MHC class II, and selectively disrupts antigen presentation.
Frauwirth K; Shastri N
Cell Immunol; 2001 May; 209(2):97-108. PubMed ID: 11446742
[TBL] [Abstract][Full Text] [Related]
16. Influence of a dominant cryptic epitope on autoimmune T cell tolerance.
Anderton SM; Viner NJ; Matharu P; Lowrey PA; Wraith DC
Nat Immunol; 2002 Feb; 3(2):175-81. PubMed ID: 11812995
[TBL] [Abstract][Full Text] [Related]
17. Superior tumor protection induced by a cellular vaccine carrying a tumor-specific T helper epitope by genetic exchange of the class II-associated invariant chain peptide.
van Bergen J; Camps M; Offringa R; Melief CJ; Ossendorp F; Koning F
Cancer Res; 2000 Nov; 60(22):6427-33. PubMed ID: 11103809
[TBL] [Abstract][Full Text] [Related]
18. Comprehensive analysis of contributions from protein conformational stability and major histocompatibility complex class II-peptide binding affinity to CD4+ epitope immunogenicity in HIV-1 envelope glycoprotein.
Li T; Steede NK; Nguyen HN; Freytag LC; McLachlan JB; Mettu RR; Robinson JE; Landry SJ
J Virol; 2014 Sep; 88(17):9605-15. PubMed ID: 24920818
[TBL] [Abstract][Full Text] [Related]
19. Identification of HLA DR7-restricted epitopes from human telomerase reverse transcriptase recognized by CD4+ T-helper cells.
Schroers R; Huang XF; Hammer J; Zhang J; Chen SY
Cancer Res; 2002 May; 62(9):2600-5. PubMed ID: 11980655
[TBL] [Abstract][Full Text] [Related]
20. On the initial trigger of myasthenia gravis and suppression of the disease by antibodies against the MHC peptide region involved in the presentation of a pathogenic T-cell epitope.
Atassi MZ; Oshima M; Deitiker P
Crit Rev Immunol; 2001; 21(1-3):1-27. PubMed ID: 11642597
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
